Literature DB >> 5716093

Action of drugs on the aqueous flow in man measured by fluorophotometry.

P Anselmi, A J Bron, D M Maurice.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5716093     DOI: 10.1016/s0014-4835(68)80002-8

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  8 in total

1.  Study on the aqueous humor flow measured by fluorophotometry after argon laser trabeculoplasty.

Authors:  D Aliseda Pérez; P C Fernández Vila; P Beneyto Martin
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

2.  A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma.

Authors:  K B Mills; A E Ridgway
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

3.  Guanethidine and adrenaline used in combination in chronic simple glaucoma.

Authors:  J A Roth
Journal:  Br J Ophthalmol       Date:  1973-07       Impact factor: 4.638

4.  Fluorescein dynamics in the eye.

Authors:  J Cunha-Vaz; D Maurice
Journal:  Doc Ophthalmol       Date:  1969       Impact factor: 2.379

5.  Sympathetic control of aqueous secretion in man.

Authors:  A J Bron
Journal:  Br J Ophthalmol       Date:  1969-01       Impact factor: 4.638

Review 6.  The flow of aqueous humor in the human eye.

Authors:  R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1982

7.  Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study).

Authors:  U Urner-Bloch; J E Aeschlimann; B P Gloor
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

8.  Evaluation of a 5% guanethidine and 0.5% adrenaline mixture (Ganda 5.05) and of a 3% guanethidine and 0.5% adrenaline mixture (Ganda 3.05) in the treatment of open-angle glaucoma.

Authors:  J Romano; G Patterson
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.